Prognostic value of histological and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma

Annals of Surgical Oncology

Volumn 17, Issue 9, 2010, Pages 2444-2451

  Rios A ^a,c   Rodriguez J M ^a   Acosta, J M ^a   Balsalobre, M D ^a   Torregrosa, N ^a   Sola, J ^a   Perez Flores D ^b   Parrilla, P ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADOLESCENT; ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER INVASION; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CELL STRUCTURE; CHILD; DISEASE FREE INTERVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PREDICTIVE VALIDITY; PRESCHOOL CHILD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; TUMOR VOLUME; VASCULAR TUMOR;

ADULT; CARCINOMA, MEDULLARY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 77956342430     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1021-4     Document Type: Article

References (46)

1. T Weber T Schilling MW Buchler 2006 Thyroid carcinoma Curr Opin Oncol. 18 30 35 16357561
2. A Ríos JM Rodríguez M Canteras PJ Galindo FJ Tebar P Parrilla 2005 Surgical management of multinodular goiter with compression symptoms Arch Surg. 140 49 53 10.1001/archsurg.140.1.49 15655205
3. A Ríos JM Rodríguez PJ Galindo M Canteras P Parrilla 2005 Surgical treatment for multinodular goitres in geriatric patients Langenbeck Arch Surg. 390 236 242 10.1007/s00423-004-0521-8
4. A Ríos JM Rodríguez M Canteras PJ Galindo MD Balsalobre T Soria P Parrilla 2004 Risk factors for malignancy in multinodular goitres Eur J Surg Oncol. 30 58 62 10.1016/j.ejso.2003.10.021 14736524
5. DW Ball 2007 Medullary thyroid cancer: monitoring and therapy Endocrinol Metab Clin North Am. 36 823 837 10.1016/j.ecl.2007.04.001 17673130
6. AD Hoff 2007 Medullary thyroid carcinoma Hematol Oncol Clin North Am. 21 475 488 10.1016/j.hoc.2007.04.002 17548035
7. E Kebebew P Ituarte A Siperstein QY Duh O Klark 2000 Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison OS staging system Cancer. 88 1139 1148 10.1002/(SICI)1097- 0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z 10699905
8. JD Brierley R Tsang WJ Simpson M Gospodarowicz S Sutcliffe T Panzarella 1996 Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control Thyroid. 6 305 310 10.1089/thy.1996.6.305 8875751
9. B Franc M Rosenberg Bourgin B Caillou, et al. 1998 Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis) Hum Pathol. 29 1078 1084 10.1016/S0046-8177(98)90417-8 9781645
10. E Modigliani R Cohen JM Campos D Conte-Devolx B Maes A Boneu, et al. 1998 Prognostic factor for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group Clin Endocrinol. 48 265 273 10.1046/j.1365-2265.1998.00392.x
11. K Gulben U Berberoglu M Boyabatli 2006 Prognostic factors for sporadic medullary thyroid carcinoma World J Surg. 30 84 90 10.1007/s00268-005-7949-z 16369705
12. S Roman R Lin JA Sosa 2006 Prognosis of medullary thyroid carcinoma: demographic, clinical and pathologic predictors of survival in 1252 cases Cancer. 107 2134 2142 10.1002/cncr.22244 17019736
13. JR Clark TR Fridman MJ Odell J Brierley PG Walfish JL Freeman 2005 Prognostic variables and calcitonin in medullary thyroid cancer Laryngoscope. 115 8 1445 1450 10.1097/01.mlg.0000168114.90852.a6 16094121
14. A Traugott JF Moley 2005 Medullary thyroid cancer: medical management and follow-up Curr Treat Options Oncol. 6 339 346 10.1007/s11864-005-0037-7 15967086
15. B Helbling K Wharton MK McLeod 2004 Medullary thyroid cancer: the controversy continues Curr Surg. 61 537 545 10.1016/j.cursur.2004.07.001 15590017
16. J Albores H Monforte M Hadji AR Morales 1988 C cell hyperplasia in thyroid tissue adjacent to follicular cell tumors Hum Pathol. 19 795 799 10.1016/S0046-8177(88)80262-4
17. U Bergholm HO Adami G Auer R Bergstrom M Backdahl, et al. 1989 Histopathological characteristics and DNA contents as prognostic factor in medullary thyroid carcinoma: a nationwide study in Sweden Cancer. 64 135 142 10.1002/1097-0142(19890701)64:1<135::AID-CNCR2820640123>3.0.CO;2-G 2731109
18. Hermanek P, Sobin LH, editors. UICC TNM classfication of malignant tumours. 4th ed. Berlin: Springer Verlag; 1987.
19. M Dottorini A Assi M Sironi G Sangalli G Spreafico L Colombo 1996 Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathological variables Cancer 77 1556 1565 10.1002/(SICI)1097-0142(19960415)77:8<1556::AID- CNCR20>3.0.CO;2-Y 8608543
20. PR Fuchshuber TR Loree WL Hicks RT Cheney DP Shedd 1998 Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations Ann Surg Oncol. 5 81 86 10.1007/BF02303768 9524712
21. NA Samaan PN Schultz RC Hickey 1988 Medullary thyroid carcinoma. Prognosis of familial versus sporadic disease and the role of radiotherapy J Clin Endocrinol Metab. 7 801 805 10.1210/jcem-67-4-801
22. J Ukkat O Gimm M Brauckhoff U Bilkenroth H Dralle 2004 Single center experience in primary surgery for medullary thyroid carcinoma World J Surg. 28 1271 1274 10.1007/s00268-004-7608-9 15517488
23. M Brauckhoff K Lorenz J Ukkat K Brauckhoff O Gimm H Dralle 2004 Medullary thyroid carcinoma Scand J Surg. 93 249 260 15658665
24. O Gimm J Ukkat BE Niederle T Weber PN Thanh M Brauckhoff B Niederle H Dralle 2004 Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634 World J Surg. 28 1312 1316 10.1007/s00268-004-7640-9 15517481
25. SL Hyer L Vini R A'Hern C Harmer 2000 Medullary thyroid cancer: multivariate analyses of prognostic factors influencing survival Eur J Surg Oncol. 26 686 690 10.1053/ejso.2000.0981 11187027
26. K Kakudo JA Carney GW Sizemore 1985 Medullary carcinoma of the thyroid. Biological behavior of the sporadic and familial neoplasm Cancer. 55 2818 2821 10.1002/1097-0142(19850615)55:12<2818::AID-CNCR2820551217>3.0.CO;2-2 2859923
27. MF Saad NG Ordonez RK Rashid JJ Guido CS Hill Jr RC Hickey NA Samaan 1984 Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients Medicine (Baltimore). 63 319 342
28. S Schröder W Böcker H Baisch, et al. 1988 Prognostic factor in medullary thyroid carcinoma. Survival in relation to age, sex, stage, histology, immunocytochemistry and DNA content Cancer. 61 806 816 10.1002/1097- 0142(19880215)61:4<806::AID-CNCR2820610428>3.0.CO;2-G 2448025
29. ED Williams CL Brown I Doniach 1966 Pathological and clinical findings in a series of 67 medullary carcinoma of the thyroid J Clin Pathol. 19 103 113 10.1136/jcp.19.2.103 5909693
30. R Holm M Sobrinho JM Nesland VE Gould JV Johanness 1985 Medullary carcinoma of the thyroid gland: an immunocytochemical study Ultrastruct Pathol. 8 25 41 10.3109/01913128509141506 3901454
31. CM Pyke ID Hay JR Goellner EJ Bergstrahl JA van Heerden CS Grant 1991 Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma Surgery. 110 964 970 1745984
32. U Bergholm R Bergstrom A Ekbom 1997 Long-term follow-up of patients with medullary carcinoma of the thyroid Cancer. 79 132 138 10.1002/(SICI)1097- 0142(19970101)79:1<132::AID-CNCR19>3.0.CO;2-5 8988737
33. G Fontanini S Vignati F Pacini L Pollina F Basolo 1996 Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma Mod Pathol. 9 634 641
34. SH Bigner EB Cox G Mendelsohn SB Baylin SA Wells Jr JC Eggleston 1981 Medullary carcinoma of the thyroid in the multiple endocrine neoplasia 2A syndrome Am J Surg Pathol. 5 459 472 10.1097/00000478-198107000-00005 7282994
35. MF Saad NG Ordonez JJ Guido NA Samaan 1984 The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid J Clin Endocrinol Metab. 59 850 856 10.1210/jcem-59-5-850 6207198
36. F Pacini F Basolo E Rossella L Fugazzola A Cola A Pinchera 1991 Medullary thyroid cancer: an immunohistochemical and humoral study using six separate antigens Am J Clin Pathol. 95 300 308 1996540
37. L Pollina F Pacini G Fontanini S Vignati G Bevilacqua F Basolo 1996 Bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas Br J Cancer. 73 139 143 8546897
38. DG Wang WH Liu CF Johnston JM Sloan KD Buchanan 1998 Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorogenesis Am J Pathol. 152 1407 1413 9626044
39. G Viale M Roncalli L Grimelius, et al. 1995 Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma Hum Pathol. 26 945 950 10.1016/0046-8177(95)90082-9 7672794
40. JD Goldenberg LG Portugal BL Wenig K Ferrer JC Wu J Sabnani 1998 Well-differentiated thyroid carcinoma: p53 status and microvessel density Head Neck. 20 152 158 10.1002/(SICI)1097-0347(199803)20:2<152::AID-HED9>3.0. CO;2-1 9484947
41. A Horii J Yoshida M Sakai S Okamoto, et al. 1999 Ki-67 positive fractions in benign and malignant thyroid tumours: application of flow cytometry Acta Otolaryngol. 119 617 620 10.1080/00016489950180883 10478606
42. LE Tisell A Oden A Muth G Altiparmak J Molne H Ahlman O Nilsson 2003 The Ki67 index a prognostic marker in medullary thyroid carcinoma Br J Cancer. 89 2093 2097 10.1038/sj.bjc.6601453 14647143
43. J Yokota T Yamamoto K Toyoshima, et al. 1986 Amplification of the c-erb-B2 oncogene in human adenocarcinomas in vivo Lancet. 1 765 767 10.1016/S0140-6736(86)91782-4 2870269
44. G Soda A Antonaci D Bosco S Nardoni M Melis 1999 Expression of bcl-2, c-erb-B2, p53, and p21 (wafl-cip1) protein in thyroid carcinoma J Exp Clin Cancer Res. 18 363 370 10606183
45. Y Ito H Yoshida Y Motoo JL Iovanna C Tomoda T Uruno Y Takamura A Miya K Kobayashi F Matsuzuka K Kuma A Miyauchi 2005 Expression of p8 protein in medullary thyroid carcinoma Anticancer Res. 25 3419 3423 16101158
46. Y Ito H Yoshida C Tomoda T Uruno Y Takamura A Miya K Kobayashi F Matsuzuka K Kuma Y Nakamura K Kakudo A Miyauchi 2005 Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosis Cancer Lett. 229 291 297 10.1016/j.canlet.2005.06.040 16095809